These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 7516271)

  • 21. Anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis might recognize restricted epitopes on myeloperoxidase molecule.
    Ye H; Zhao MH; Gao Y; Guo XH; Wang HY
    Clin Exp Immunol; 2004 Oct; 138(1):179-82. PubMed ID: 15373922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-neutrophil cytoplasm antibodies in HIV infection.
    Savige JA; Chang L; Crowe SM
    Adv Exp Med Biol; 1993; 336():349-52. PubMed ID: 8296633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lesions of the respiratory tract associated with the finding of anti-neutrophil cytoplasmic autoantibodies with a perinuclear staining pattern.
    DeRemee RA; Homburger HA; Specks U
    Mayo Clin Proc; 1994 Sep; 69(9):819-24. PubMed ID: 8065182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pathologic spectrum of pulmonary lesions in patients with anti-neutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and anti-myeloperoxidase.
    Gaudin PB; Askin FB; Falk RJ; Jennette JC
    Am J Clin Pathol; 1995 Jul; 104(1):7-16. PubMed ID: 7611186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diverse target antigens recognized by circulating antibodies in anti-neutrophil cytoplasm antibody-associated renal vasculitides.
    Savige JA; Gallicchio M; Georgiou T; Davies DJ
    Clin Exp Immunol; 1990 Nov; 82(2):238-43. PubMed ID: 1978702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atypical autoantigen targets of perinuclear antineutrophil cytoplasm antibodies (P-ANCA): specificity and clinical associations.
    Lesavre P; Noël LH; Gayno S; Nusbaum P; Reumaux D; Erlinger S; Grünfeld JP; Halbwachs-Mecarelli L
    J Autoimmun; 1993 Apr; 6(2):185-95. PubMed ID: 8388691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of monoclonal antibodies to proteinase 3 (PR3) as candidate tools for epitope mapping of human anti-PR3 autoantibodies.
    Van Der Geld YM; Limburg PC; Kallenberg CG
    Clin Exp Immunol; 1999 Dec; 118(3):487-96. PubMed ID: 10594572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of risk epitopes of anti-neutrophil antibody MPO-ANCA in vasculitis in Japanese population.
    Suzuki K; Kobayashi S; Yamazaki K; Gondo M; Tomizawa K; Arimura Y; Nakabayashi K; Ozaki S; Yoshida M; Yoshida T; Tsusaka N; Muso E; Okazaki T; Hashimoto H
    Microbiol Immunol; 2007; 51(12):1215-20. PubMed ID: 18094540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eosinophil peroxidase differs from neutrophil myeloperoxidase in its ability to bind antineutrophil cytoplasmic antibodies reactive with myeloperoxidase.
    Sullivan S; Salapow MA; Breen R; Broide DH
    Int Arch Allergy Immunol; 1994 Oct; 105(2):150-4. PubMed ID: 7920015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indirect immunofluorescence (IIF) of normal washed peripheral blood cells to demonstrate antineutrophil cytoplasmic antibodies (ANCA).
    Paspaliaris B; Pamio M; Savige J
    J Clin Pathol; 2000 Oct; 53(10):774-7. PubMed ID: 11064672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-neutrophil cytoplasmic autoantibodies (ANCA): antigenic specificities and clinical associations.
    Bosch X; Font J; Mirapeix E; Revert L; Urbano-Márquez A; Ingelmo M
    Adv Exp Med Biol; 1993; 336():281-6. PubMed ID: 8296618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigen-specific radioimmunoassays for anti-neutrophil cytoplasmic antibodies in the diagnosis of rapidly progressive glomerulonephritis.
    Niles JL; Pan GL; Collins AB; Shannon T; Skates S; Fienberg R; Arnaout MA; McCluskey RT
    J Am Soc Nephrol; 1991 Jul; 2(1):27-36. PubMed ID: 1655091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of ANCA in 98 patients.
    Geffriaud-Ricouard C; Noël LH; Chauveau D; Houhou S; Grünfeld JP; Lesavre P
    Adv Exp Med Biol; 1993; 336():273-9. PubMed ID: 7905232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of monoclonal antibodies to proteinase-3 and application in the study of epitopes for classical anti-neutrophil cytoplasm antibodies.
    Sommarin Y; Rasmussen N; Wieslander J
    Exp Nephrol; 1995; 3(4):249-56. PubMed ID: 8590038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-neutrophil cytoplasm antibodies can recognize vascular endothelial cell-bound anti-neutrophil cytoplasm antibody-associated autoantigens.
    Savage CO; Gaskin G; Pusey CD; Pearson JD
    Exp Nephrol; 1993; 1(3):190-5. PubMed ID: 7915959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha 1-antitrypsin deficiency and anti-proteinase 3 antibodies in anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis.
    Savige JA; Chang L; Cook L; Burdon J; Daskalakis M; Doery J
    Clin Exp Immunol; 1995 May; 100(2):194-7. PubMed ID: 7743654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.
    Hagen EC; Daha MR; Hermans J; Andrassy K; Csernok E; Gaskin G; Lesavre P; Lüdemann J; Rasmussen N; Sinico RA; Wiik A; van der Woude FJ
    Kidney Int; 1998 Mar; 53(3):743-53. PubMed ID: 9507222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ANCA and IgG subclasses.
    Segelmark M; Wieslander J
    Adv Exp Med Biol; 1993; 336():71-5. PubMed ID: 8296678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
    Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D
    Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epitope mapping of anti-PR3 antibodies using chimeric human/mouse PR3 recombinant proteins.
    Selga D; Segelmark M; Wieslander J; Gunnarsson L; Hellmark T
    Clin Exp Immunol; 2004 Jan; 135(1):164-72. PubMed ID: 14678279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.